Светлана Проценко
- Co-authors
- Lev DemidovCaroline RobertGrant A. McArthurPaolo A. AsciertoRalf GutzmerThomas EigentlerDaniil StroyakovskiyPiotr Rutkowski
- Topics
- Cancer Immunotherapy and Biomarkers (24 papers)CAR-T cell therapy research (16 papers)Immunotherapy and Immune Responses (13 papers)
- Cited by
- OncologyImmunologyMolecular Biology
- Journals
- The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- RussiaUnited StatesFrance
In The Last Decade
Светлана Проценко
42 papers receiving 700 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 621
- Molecular Biology 298
- Immunology 176
- Pulmonary and Respiratory Medicine 118
- Cancer Research 59
Countries citing papers authored by Светлана Проценко
This map shows the geographic impact of Светлана Проценко's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Светлана Проценко with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Светлана Проценко more than expected).
Fields of papers citing papers by Светлана Проценко
This network shows the impact of papers produced by Светлана Проценко. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Светлана Проценко. The network helps show where Светлана Проценко may publish in the future.
Co-authorship network of co-authors of Светлана Проценко
This figure shows the co-authorship network connecting the top 25 collaborators of Светлана Проценко. A scholar is included among the top collaborators of Светлана Проценко based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Светлана Проценко. Светлана Проценко is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 37 | |
| 8 | 0 | |
| 9 | 10 | |
| 10 | 5 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 2 | |
| 14 | 0 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | [Gefitinib therapy in advanced non-small cell lung cancer in patients with EGFR mutations: cost-effectiveness analysis]. | 1 |
| 18 | 5 | |
| 19 | 16 | |
| 20 | Modern options in personalized therapy of metastatic cutaneous melanoma | 1 |
About Светлана Проценко
Светлана Проценко is a scholar working on Oncology, Immunology and Cancer Research, having authored 63 papers that have together received 737 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), CAR-T cell therapy research (16 papers) and Immunotherapy and Immune Responses (13 papers). The work is most often cited by research in Oncology (621 citations), Immunology (176 citations) and Molecular Biology (298 citations). Светлана Проценко has collaborated with scholars based in Russia, United States and France. Frequent co-authors include Lev Demidov, Caroline Robert, Grant A. McArthur, Paolo A. Ascierto, Ralf Gutzmer, Thomas Eigentler, Daniil Stroyakovskiy, Piotr Rutkowski, Karl D. Lewis and Rodrigo Perez Pereira. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.